Clinuvel Pharmaceuticals (ASX:CUV) reveals “positive” final results of pilot study CUV801
Clinuvel Pharmaceuticals (CUV) confirms its pilot study, CUV801, has delivered positive results…
Clinuvel Pharmaceuticals Limited (ASX:CUV)
About Clinuvel Pharmaceuticals Limited
Key Information
CUV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 26/04/2024 | Ceasing to be a substantial holder | 856.04KB | 689 |
| 22/04/2024 | CLINUVEL expands global leadership team | 76.98KB | 3.6K |
| 15/04/2024 | Change to executive management | 63.29KB | 2.7K |
| 12/04/2024 | Update - Notification of buy-back - CUV | 15.7KB | 2.4K |
| 10/04/2024 | Update - Notification of buy-back - CUV | 15.69KB | 1.6K |
| 09/04/2024 | Update - Notification of buy-back - CUV | 15.68KB | 2.0K |
| 09/04/2024 | Becoming a substantial holder | 1.22MB | 374 |
| 04/04/2024 | Notification of cessation of securities - CUV | 12.69KB | 346 |